Flotte TR - Search Results

1

Recombinant adeno-associated virus integration sites in murine liver after ornithine transcarbamylase gene correction.

Zhong L, Malani N, Li M, Brady T, Xie J, Bell P, Li S, Jones H, Wilson JM, Flotte TR, Bushman FD, Gao G. Zhong L, et al. Among authors: flotte tr. Hum Gene Ther. 2013 May;24(5):520-5. doi: 10.1089/hum.2012.112. Hum Gene Ther. 2013. PMID: 23621841 Free PMC article.

2

Adeno-associated virus vectors for gene therapy.

Flotte TR, Carter BJ. Flotte TR, et al. Gene Ther. 1995 Aug;2(6):357-62. Gene Ther. 1995. PMID: 7584109 Review.

3

In vivo gene therapy with adeno-associated virus vectors for cystic fibrosis.

Flotte TR, Carter BJ. Flotte TR, et al. Adv Pharmacol. 1997;40:85-101. doi: 10.1016/s1054-3589(08)60138-6. Adv Pharmacol. 1997. PMID: 9217924 Review. No abstract available.

4

A fluorescence video-endoscopy technique for detection of gene transfer and expression.

Flotte TR, Beck SE, Chesnut K, Potter M, Poirier A, Zolotukhin S. Flotte TR, et al. Gene Ther. 1998 Feb;5(2):166-73. doi: 10.1038/sj.gt.3300579. Gene Ther. 1998. PMID: 9578835

5

Inhibition of recombinant adeno-associated virus (rAAV) transduction by bronchial secretions from cystic fibrosis patients.

Virella-Lowell I, Poirier A, Chesnut KA, Brantly M, Flotte TR. Virella-Lowell I, et al. Among authors: flotte tr. Gene Ther. 2000 Oct;7(20):1783-9. doi: 10.1038/sj.gt.3301268. Gene Ther. 2000. PMID: 11083501

6

Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy.

Flotte TR. Flotte TR. Curr Opin Mol Ther. 2001 Oct;3(5):497-502. Curr Opin Mol Ther. 2001. PMID: 11699895 Review.

7

Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects.

Song S, Scott-Jorgensen M, Wang J, Poirier A, Crawford J, Campbell-Thompson M, Flotte TR. Song S, et al. Among authors: flotte tr. Mol Ther. 2002 Sep;6(3):329-35. doi: 10.1006/mthe.2002.0673. Mol Ther. 2002. PMID: 12231168 Free article.

8

Production of clinical-grade recombinant adeno-associated virus vectors.

Snyder RO, Flotte TR. Snyder RO, et al. Among authors: flotte tr. Curr Opin Biotechnol. 2002 Oct;13(5):418-23. doi: 10.1016/s0958-1669(02)00369-5. Curr Opin Biotechnol. 2002. PMID: 12459331 Review.

9

Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study.

Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S, Conrad CK, Brass-Ernst L, Humphries M, Sullivan K, Wetzel R, Taylor G, Carter BJ, Guggino WB. Flotte TR, et al. Hum Gene Ther. 2003 Jul 20;14(11):1079-88. doi: 10.1089/104303403322124792. Hum Gene Ther. 2003. PMID: 12885347 Clinical Trial.

10

Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver.

Loiler SA, Conlon TJ, Song S, Tang Q, Warrington KH, Agarwal A, Kapturczak M, Li C, Ricordi C, Atkinson MA, Muzyczka N, Flotte TR. Loiler SA, et al. Among authors: flotte tr. Gene Ther. 2003 Sep;10(18):1551-8. doi: 10.1038/sj.gt.3302046. Gene Ther. 2003. PMID: 12907946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters